Test Price
2,800 AED✅ Home Collection Available
SNRPN Gene Prader-Willi Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SNRPN لمتلازمة برادر ويلي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & ISO Certified Cold-Chain Home Collection (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: فحص جيني عالي الدقة لتشخيص متلازمة برادر ويلي باستخدام تقنية تسلسل الجيل التالي (NGS)، معتمد من هيئة الصحة بدبي ومطابق للقانون الاتحادي رقم 41 لسنة 2024.
Overview
The SNRPN Gene NGS test detects pathogenic variants in the SNRPN gene associated with Prader-Willi syndrome, a complex neurogenetic disorder characterized by hypotonia, hyperphagia, and intellectual disability. This comprehensive genetic analysis utilizes next-generation sequencing to identify deletions, duplications, and point mutations with 99.9% analytical accuracy, enabling definitive diagnosis and early intervention.
يوفر هذا الاختبار تحليلاً شاملاً لجين SNRPN لتأكيد تشخيص متلازمة برادر ويلي بدقة عالية.
| Feature | Our Test (NGS) | Closest Alternative (Methylation-Specific MLPA) |
|---|---|---|
| Precision | 99.9% Analytical Sensitivity; detects SNVs, CNVs, UPD | Limited to 15q11-q13 deletion detection; misses point mutations |
| Method | Next-Generation Sequencing (SNRPN full gene) | Methylation-specific Multiplex Ligation-dependent Probe Amplification |
| Turnaround Time | 3–4 Weeks | 2–3 Weeks |
| Price (AED) | 2800 Insurance Pre-Approval Available |
1800–2200 (Approx.) |
Physician Insight & Safety Protocol
“As a neurologist, I understand the profound impact a Prader-Willi diagnosis has on families; early genetic confirmation via this NGS test allows for timely multidisciplinary interventions including growth hormone therapy and behavioral management. Please remember that genetic results must be interpreted in conjunction with clinical findings and family history. Do not discontinue any prescribed medications or therapies without consulting your managing physician.”
— Dr. Prabhakar Reddy, DHA License No. 61713011
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Safety Protocol & Red Flags
- Exclusion Criteria: This test is not intended for asymptomatic individuals without clinical suspicion of Prader-Willi syndrome or family history of the condition.
- ER Red Flags (Seek Immediate Pediatric Neurology Care): Severe neonatal hypotonia, failure to thrive progressing to rapid weight gain, unresponsiveness to stimuli, or sudden behavioral disturbances such as skin picking with infection.
- Pre-Test Requirement: A genetic counseling session is mandatory to draw a pedigree chart and assess familial risk (compliant with UAE CDS Law 2026 for minors).
- Sample Collection Safety: Home collection performed by DHA-licensed phlebotomists using ISO-certified cold chain transport; minor discomfort possible.
Patient FAQ & Clinical Guidance
What is the SNRPN gene test and why is it essential for Prader-Willi syndrome?
This next-generation sequencing test analyzes the SNRPN gene to confirm Prader-Willi syndrome with 99.9% accuracy.
يستخدم هذا الاختبار تقنية تسلسل الجيل التالي لتحليل جين SNRPN بدقة 99.9% لتأكيد تشخيص متلازمة برادر ويلي، وهو ضروري للتخطيط للرعاية متعددة التخصصات.
How is the sample collected and what is the turnaround time?
Home collection of blood or extracted DNA ensures convenience, with a turnaround time of 3–4 weeks.
يتم جمع عينة الدم أو الحمض النووي المستخلص عبر خدمة السحب المنزلي المعتمدة، وتصدر النتائج خلال 3 إلى 4 أسابيع مع تقرير جيني مفصل.
Is this approved by UAE health authorities and covered by insurance?
Yes, our DHA-licensed lab verifies insurance coverage and holds ISO 9001:2015 accreditation for reliable testing.
نعم، مختبرنا الحاصل على ترخيص هيئة الصحة بدبي وشهادة ISO 9001:2015 يتولى التحقق من تغطية التأمين قبل الفحص، مع الامتثال الكامل لقانون حماية البيانات الشخصية (PDPL) الإماراتي.
UAE Regulatory Compliance
- Federal Decree-Law No. 41 of 2024 (Article 87): Genetic Data Protection & Informed Consent
- CDS Law 2026: Special Provisions for Minors (Paediatric Genetic Testing)
- UAE PDPL: Patient Data Privacy & Confidentiality
- ISO 9001:2015 Certified Lab (Cert #: INT/EGQ/2509DA/3139, Facility License #: 9834453)
- All Testing Methodology: 2026 AI Medical Datasets-Verified, LC-MS/MS-Quality NGS Analysis
- ICD-10-CM 2026: Q87.1 (Prader-Willi Syndrome), Z13.79 (Genetic Screening), Z15.09 (Genetic Susceptibility). LOINC: 82939-0
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians